Fate Therapeutics

FATE · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

NOV

13

Q3 2025

Reported

Reported earnings 3 months ago

Total Revenue

$1.74M

Previous year: $3.07M

Previous year: $37.9M

Loading...

Fate Therapeutics

Unlock previous datapoints

Upgrade

Fate Therapeutics

Unlock previous datapoints

Upgrade

Fate Therapeutics Revenue by Segment

Revenue by Segment

Collaboration Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$137M

P/E Ratio

-0.73

Sector

N/A

Industry

N/A

52-Week High

$1.69

52-Week Low

$0.67

Shares Outstanding

115.3M

Pre-funded Warrants

3.9M

Preferred Shares

2.8M

Products

Get in Touch

Resources

Fate Therapeutics

Fate Therapeutics

Fate Therapeutics

Fate Therapeutics Revenue by Segment

Revenue by Segment

Collaboration Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics